Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Rang in Aktien #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Aktienkurs
$25.61
Zuletzt synchronisiert: 2025-10-10
Marktkapitalisierung
$1.37B
Veränderung (1 Tag)
0.20%
Veränderung (1 Jahr)
1.55%
Land
US
Handel Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategorie

Aktien-Split-Historie für Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Die Aktie Harrow Health, Inc. 8.625% Senior Notes due 2026 (Symbol: HROWL) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 29, 2026 statt.
Eine HROWL-Aktie, die vor dem Aug 29, 2026 gekauft wurde, entspricht heute 0 HROWL-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber